李佳蓓,黄岚

• 1:第三军医大学附属新桥医院全军心血管病研究所

摘要(Abstract)：

关键词(KeyWords)：

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 李佳蓓,黄岚

参考文献(References)：

• [1]Nguyen TA,Diodati JG,Pharand C.Resistance to clopidogrel:a review of the evidence.J Am Coll Cardiol,2005,45:1157.1164.
• [2]Wiviott SD,Antman EM.Clopidogrel resistance:a new chapter in a fast.moving story.Circulation,2004,109:3064.3067.
• [3]Gurbel PA,Bliden KP,Samara W,et al.Clopidogrel effect on platelet reactivity in patients with stent thrombosis:results of the CRESTstudy.J Am Coll Cardiol,2005,46:1827.1832.
• [4]Gurbel PA,Tantry US.Clopidogrel resistance?Thromb Res,2007,120:311.321.
• [5]Suh JW,Koo BK,Zhang SY,et al.Increased risk of athero.thrombotic events associated with cytochrome P4503A5polymor.phism in patients taking clopidogrel.CMAJ,2006,174:1715.1722.
• [6]Angiolillo DJ,Fernandez.Ortiz A,Bernardo E,et al.Contribu.tion of gene sequence variations of the hepatic cytochrome P4503A4enzyme to variability in individual responsiveness to clopi.dogrel.Arterioscler Thromb Vasc Biol,2006,26:1895.1900.
• [7]Kim K,Park P,Hong S,et al.The effect of CYP2C19polymor.phism on the pharmacokinetics and pharmacodynamics of clopi.dogrel:a possible mechanism for clopidogrel resistance.Clin Pharmacol Ther,2008,84:236.242.
• [8]Fontana P,Dupont A,Gandrille S,et al.Adenosine diphos.phate.induced platelet aggregation is associated with P2Y12gene sequence variations in healthy subjects.Circulation,2003,108:989.995.
• [9]Di Castelnuovo A,de Gaetano G,Benedetta Donati M,et al.Platelet glycoproteinⅡb/Ⅲa polymorphism and coronary artery disease:implications for clinical practice.Am J Pharmacogenom.ics,2005,5:93.99.
• [10]Papp E,Havasi V,Bene J,et al.Does glycoproteinⅢa gene(Pl(A))polymorphism influence clopidogrel resistance:a studyin older patients.Drugs Aging,2007,24:345.50.
• [11]Ziegler S,Schillinger M,Funk M,et al.Association of a func.tional polymorphism in the clopidogrel target receptor gene,P2Y12,and the risk for ischemic cerebrovascular events in pa.tients with peripheral artery disease.Stroke,2005,36:1394.1399.
• [12]Michelson AD,Linden MD,Furman MI,et al.Evidence that pre.existent variability in platelet response to ADP accounts for'clopidogrel resistance'.J Thromb Haemost,2007,5:75.81.
• [13]Gurbel PA,Bliden KP,Hayes KM,et al.The relation of dosing to clopidogrel responsiveness and the incidence of high post.treat.ment platelet aggregation in patients undergoing coronary stent.ing.J Am Coll Cardiol,2005,45:1392.1396.
• [14]von Beckerath N,Kastrati A,Wieczorek A,et al.A double.blind randomized comparison between two different clopidogrel maintenance doses after percutaneous coronary intervention(ISAR.CHOICE2Trial).Eur Heart J,2006,27:5039.
• [15]Hamann GF,Weimar C,Glahn J,et al.Adherence to secondary stroke prevention strategies.results from the German Stroke Data Bank.Cerebrovasc Dis,2003,15:282.288.
• [16]Gorchakova O,von Beckerath N,Gawaz M,et al.Antiplatelet effects of a600mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least4weeks prior to coronary artery stenting.Eur Heart J,2004,25:1898.1902.
• [17]Feher G,Koltai K,Alkonyi B,et al.Clopidogrel resistance:role of body mass and concomitant medications.Int J Cardiol,2007,120:188.192.
• [18]Smith D.Drug interaction with anti.mycobacterial treatment as a cause of clopidogrel resistance.Postgrad Med J,2008,84:217.219.
• [19]Angiolillo DJ,Fernandez.Ortiz A,Bernardo E,et al.Platelet function profiles in patients with type2diabetes and coronary ar.tery disease on combined aspirin and clopidogrel treatment.Dia.betes,2005,54:2430.2435.
• [20]Geisler T,Langer H,Wydymus M,et al.Lowresponse to clopi.dogrel is associated with cardiovascular outcome after coronary stent implantation.Eur Heart J,2006,27:2420.2425.
• [21]Bonello L,Camoin.Jau L,Arques S,et al.Adjusted Clopidogrel Loading Doses According to Vasodilator.Stimulated Phosphopro.tein Phosphorylation IndexDecrease Rate of Major Adverse Cardi.ovascular Events in Patients With Clopidogrel Resistance.J Am Coll Cardiol,2008,51:1404.1411.
• [22]Lee BK,Lee SW,Park SW,et al.Effects of triple antiplatelet therapy(aspirin,clopidogrel,and cilostazol)on platelet aggre.gation and P.selectin expression in patients undergoing coronary artery stent implantation.Am J Cardiol,2007,100:610.614.